Literature DB >> 8946229

The effect of angiotensin II on myosin heavy chain expression in cultured myocardial cells.

N Shalitin1, M Friedman, H Schlesinger, Y Barhum, M J Levy, W Schaper, G Kessler-Icekson.   

Abstract

Angiotensin II (AII), the principal mediator of the renin-angiotensin system, is an important regulator of vascular and cardiac homeostasis. AII has also been shown to be a regulator of cardiac hypertrophy and of the corresponding changes in amount and composition of certain tissue proteins. We examined the trophic effects of AII on cultured myocytes derived from neonatal rat ventricles and followed, by Northern blot analysis and polyacrylamide gel electrophoresis, the expression of alpha- and beta-myosin heavy chain iso-mRNAs and isoproteins. Our findings show that a single administration of AII is sufficient to induce a trophic response in cultured beating myocytes and to enhance the expression of beta-myosin heavy chain iso-mRNA and isoprotein, having no effect on alpha-myosin heavy chain. Induction of alpha-myosin heavy chain expression by thyroid hormone before AII was administered showed that AII could not potentiate a shift from alpha- to beta-myosin heavy chain predominance. We suggest that the potency of AII to regulate the expression of myosin heavy chain isogenes is restricted to the beta isoform and is overridden by thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946229     DOI: 10.1007/bf02722984

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  40 in total

Review 1.  Nonpeptide angiotensin II receptor antagonists.

Authors:  P B Timmermans; P C Wong; A T Chiu; W F Herblin
Journal:  Trends Pharmacol Sci       Date:  1991-02       Impact factor: 14.819

2.  Stretching cardiac myocytes stimulates protooncogene expression.

Authors:  I Komuro; T Kaida; Y Shibazaki; M Kurabayashi; Y Katoh; E Hoh; F Takaku; Y Yazaki
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

3.  Contraction regulates myosin synthesis and myosin content of cultured heart cells.

Authors:  P McDermott; M Daood; I Klein
Journal:  Am J Physiol       Date:  1985-10

4.  Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in the rabbit. A characterization of heat liberation in normal and hypertrophied right ventricular papillary muscles.

Authors:  N R Alpert; L A Mulieri
Journal:  Circ Res       Date:  1982-04       Impact factor: 17.367

5.  Alpha 1-adrenergic stimulation of rat myocardial cells increases protein synthesis.

Authors:  R S Meidell; A Sen; S A Henderson; M F Slahetka; K R Chien
Journal:  Am J Physiol       Date:  1986-11

6.  Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating.

Authors:  P Simpson
Journal:  Circ Res       Date:  1985-06       Impact factor: 17.367

7.  Effects of amiodarone on beating rate and Na-K-ATPase activity in cultured neonatal rat heart myocytes.

Authors:  M Bergman; F Cohen; H Schlesinger; G Kessler-Icekson
Journal:  Gen Pharmacol       Date:  1995-03

8.  Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

Authors:  J Sadoshima; S Izumo
Journal:  Circ Res       Date:  1993-09       Impact factor: 17.367

Review 9.  Intracardiac generation of angiotensin and its physiologic role.

Authors:  K Lindpaintner; M Jin; M J Wilhelm; F Suzuki; W Linz; B A Schoelkens; D Ganten
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

10.  Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; T Mizuno; H Takano; Y Hiroi; K Ueki; K Tobe
Journal:  Circ Res       Date:  1995-08       Impact factor: 17.367

View more
  6 in total

1.  Fluorescence spectra of cardiac myosin and in vivo experiment: studies on daunorubicin-induced cardiotoxicity.

Authors:  Yang Liu; Chi Chen; Xiaoxiang Duan; Wenting Ma; Man Wang; Mengyi Tu; Ying Chen
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

2.  The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity.

Authors:  Nataly Tarasenko; Gania Kessler-Icekson; Pnina Boer; Aida Inbal; Hadassa Schlesinger; Don R Phillips; Suzanne M Cutts; Abraham Nudelman; Ada Rephaeli
Journal:  Invest New Drugs       Date:  2010-09-23       Impact factor: 3.850

3.  Isolation and fluorescence spectrum of cardiac myosin from pig heart.

Authors:  Yang Liu; Buhai Li; Xiaomei Sun; Aihua Lin
Journal:  Protein J       Date:  2009-05       Impact factor: 2.371

4.  Late plasma exosome microRNA-21-5p depicts magnitude of reverse ventricular remodeling after early surgical repair of primary mitral valve regurgitation.

Authors:  Fausto Pizzino; Giulia Furini; Valentina Casieri; Massimiliano Mariani; Giacomo Bianchi; Simona Storti; Dante Chiappino; Stefano Maffei; Marco Solinas; Giovanni Donato Aquaro; Vincenzo Lionetti
Journal:  Front Cardiovasc Med       Date:  2022-07-29

5.  Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance.

Authors:  Yifat Alcalay; Edith Hochhauser; Vitaly Kliminski; Julia Dick; Muayad A Zahalka; Doris Parnes; Hadassa Schlesinger; Zaid Abassi; Asher Shainberg; Roland F R Schindler; Thomas Brand; Gania Kessler-Icekson
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

6.  Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity.

Authors:  A Rephaeli; S Waks-Yona; A Nudelman; I Tarasenko; N Tarasenko; D R Phillips; S M Cutts; G Kessler-Icekson
Journal:  Br J Cancer       Date:  2007-05-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.